Literature DB >> 14520637

Rapidly progressive irreversible renal failure in patients with pancreatic insufficiency.

Peter Hill1, Mahzuz Karim, David R Davies, Ian S D Roberts, Christopher G Winearls.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14520637     DOI： 10.1016/s0272-6386(03)00948-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  7 in total

1.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

2.  Prucalopride-associated acute tubular necrosis.

Authors:  Vithika Sivabalasundaram; Flavio Habal; David Cherney
Journal:  World J Clin Cases       Date:  2014-08-16       Impact factor: 1.337

3.  Vitamin C-induced oxalate nephropathy.

Authors:  Jorge Lamarche; Reji Nair; Alfredo Peguero; Craig Courville
Journal:  Int J Nephrol       Date:  2011-03-16

4.  Secondary oxalosis induced acute kidney injury in allograft kidneys.

Authors:  Manish Suneja; Avinash B Kumar
Journal:  Clin Kidney J       Date:  2013-01-04

5.  Enteric hyperoxaluria in chronic pancreatitis.

Authors:  Nathalie Demoulin; Zaina Issa; Ralph Crott; Johann Morelle; Etienne Danse; Pierre Wallemacq; Michel Jadoul; Pierre H Deprez
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

6.  Hidden in Plain Sight: An Unusual Cause of Rapidly Progressive Renal Failure.

Authors:  S V Vyahalkar; N M Dedhia; M M Bahadur; G S Sheth; V K Joglekar; V M Sawardekar; S S Khan; S M Shaikh
Journal:  Indian J Nephrol       Date:  2018 May-Jun

7.  Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.

Authors:  Karin Purshouse; Sarah Chamberlain; Maria Soares; Mark Tuthill; Andrew Protheroe; David R Mole
Journal:  BMC Cancer       Date:  2019-10-17       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.